Feature

Confronting India’s Metabolic Crisis: The Rising Threat of Syndrome X

The World Health Organization (WHO) warns that lifestyle diseases could cost India over USD 6 trillion by 2030, with a significant toll on quality of life for those affected by NCDs. What makes this situation even more concerning is that, unlike in developed countries where NCDs typically emerge at age 55 and older, in India, these diseases often appear almost a decade earlier, affecting individuals as young as 45.

• By Maadhavi Chaudhary
• New Delhi
• Aug 14, 2024

Feature

In India, the prevalence of infectious diseases—those that spread through contact—has become relatively lower compared to the rise of non-communicable diseases (NCDs). Alarming statistics reveal that about 10% of the population suffers from diabetes, 35% battle hypertension, and roughly 28% have elevated cholesterol levels. The World Health Organization (WHO) warns that lifestyle diseases could cost India over USD 6 trillion by 2030, with a significant toll on quality of life for those affected by NCDs. What makes this situation even more concerning is that, unlike in developed countries where NCDs typically emerge at age 55 and older, in India, these diseases often appear almost a decade earlier, affecting individuals as young as 45.

Living in a world where a significant portion of the population is already predisposed to developing lifestyle-induced NCDs, it is crucial to address the rising concern of a new metabolic abnormality cluster—metabolic syndrome. Also known as Syndrome X, metabolic syndrome refers to the simultaneous presence of several metabolic abnormalities, which are recognized as cardiovascular risk factors and primary contributors to Type 2 diabetes. This syndrome increases the likelihood of developing diabetes mellitus fivefold and doubles the risk of cardiovascular disease over the next 5-10 years. As I reflect on this emerging health crisis, I realize how vital it is to raise awareness and take preventive measures to combat these interconnected conditions before they further impact our lives.

The Lethal tetrad of Syndrome X

The four main abnormalities associated with metabolic syndrome are insulin resistance, visceral obesity, atherogenic dyslipidemia, and hypertension. The presence of any one of these conditions necessitates testing and diagnosis for metabolic syndrome, given its progressive nature and significant impact on quality of life. This syndrome has become a global issue due to rapid urbanization, sedentary lifestyles, and excessive energy intake.

Over the past decade, the prevalence of metabolic syndrome has reached 34.5% overall, affecting 33.5% of men and 35.4% of women. The sharper rise in the number of women developing metabolic syndrome is attributed to the tendency for central obesity in postmenopausal women, which places them at a higher risk for cardiovascular diseases.

Beyond affecting daily life, metabolic syndrome also imposes a substantial financial burden on individuals. Research indicates that those with this condition incur at least 20% higher expenses due to increased medication needs and frequent hospitalizations.

Taming the Silent Threat

It is crucial to stop this "hidden volcano" before it causes further damage. Achieving this requires healthcare professionals to be vigilant in identifying the early signs of metabolic syndrome before they fully manifest. By recognizing and addressing these warning signs early, we can mitigate the syndrome's impact and improve the quality of life for those affected.